Preformed and newly formed mediators released from mast cells play a central role in protective or pathologic immediate hypersensitivity reactions. Mast cell mediator release also appears to contribute to some complement-mediated reactions, to the expression or regulation of lymphocyte-mediated reactions, to some forms of nonspecific inflammation, and to some physiologic responses. The long term objectives of this proposal are to resolve the biochemical basis of mast cell membrane fusion - the mechanism of preformed mediators release; and the release of arachidonic acid - the precursor of several newly formed mediators. Recent experiments in this and other laboratories have provided biologic precedents and direct evidence in rat mast cells that alterations in the metabolism of sn-1,2-diacylglycerol (DAG) and of phosphatidic acid (PA) may play pivotal roles in mast cell mediator release.
The specific aims of this proposal are: 1.) to examine the origins and fates of DAG in stimulated rat mast cells with particular emphasis on phospholipase C, phosphatidate phosphohydrolase, DAG kinase and DAG-lipase; 2.) to measure the levels, origins and fates of other fusogenic lipids in stimulated rat mast cells with emphasis on DAG, sn-1 or 2-monoacylglycerol and lysophospholipids; 3.) to examine the origins and fate of newly formed P A in stimulated mast cells; 4.) to determine the reactions that make arachidonic acid (AA) available for the synthesis of newly formed mediators in stimulated mast cells; 5.) to probe the intracellular systems that regulate these reactions; and 6.) to determine whether or not rat mast cells express protein kinase activity that is activated by DAG (""""""""protein kinase C"""""""") and if present to characterize the activity in detail. Identification and characterization of the reactions that lead to membrane fusion and AA availability in mast cells are fundamental to an understanding of Ige-mediated reactions at the molecular level. Improved knowledge of the mechanisms of mediator release might permit the development of new approaches to purposeful regulation that in turn eventually might be applied to improve the management of human allergic or other inflammatory disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019801-04
Application #
3129229
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1983-04-01
Project End
1988-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Kennerly, D A (1987) Preparation and characterization of mast cell cytoplasts. J Immunol Methods 97:173-83
Tharp, M D; Kagey-Sobotka, A; Fox, C C et al. (1987) Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol 79:646-53
Myers, C D; Kriz, M K; Sullivan, T J et al. (1987) Antigen-induced changes in phospholipid metabolism in antigen-binding B lymphocytes. J Immunol 138:1705-11
Hafler, D A; Fallis, R J; Dawson, D M et al. (1986) Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12. Neurology 36:777-84
Kriz, M K; Vitetta, E S; Sullivan, T J (1986) Changes in phospholipid metabolism during B lymphocyte activation. J Immunol 137:478-83
Royer, H D; Ramarli, D; Acuto, O et al. (1985) Genes encoding the T-cell receptor alpha and beta subunits are transcribed in an ordered manner during intrathymic ontogeny. Proc Natl Acad Sci U S A 82:5510-4
Fabbi, M; Acuto, O; Bensussan, A et al. (1985) Production and characterization of antibody probes directed at constant regions of the alpha and beta subunit of the human T cell receptor. Eur J Immunol 15:821-7